Article
One-Pot Assay Based on CRISPR/Cas13a Technology for HEV RNA Point-of-Care Testing.
Journal of medical virology - 1 Dec 2024
Fan Zihao, Xu Ling, Cao Yaling, Liu Tianxu, Tian Yuan, Pan Zhenzhen, Mo Yinkang, Wang Xinyu, Zhu Xianru, Gao Yao, Zhang Xiangying, Pan Calvin Q, Wang Lin, Ren Feng
Abstract excerpt
Hepatitis E virus (HEV) poses a serious threat to both public health and animal food safety, thereby highlighting the demands for rapid, sensitive, and easy-to-use detection. This study aimed to develop a One-Pot assay using CRISPR/Cas13a for detecting HEV RNA, suitable for point-of-care testing (POCT) in resource-limited settings. CRISPR/Cas13a combined with reverse transcription polymerase chain reaction...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
